CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive™, a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, welcomes Stephen D. Silberstein, M.D., as its new editor in chief.
Silberstein is a professor of neurology and director of the Jefferson Headache Center at Thomas Jefferson University Hospital who lectures extensively on the pathogenesis, neurobiology, diagnosis and treatment of headache.
“We look forward to having Dr. Silberstein join the NeurologyLive™ team,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of NeurologyLive™. “Dr. Silberstein is the perfect leader for NeurologyLive™, and we’re so excited that he accepted this role and will help improve our team’s ability to grow and be the go-to resource for neurology professionals.”
As one of the leading experts in neurology, Silberstein brings more than 40 years of distinguished medical service to the role. He has been certified by the United Council for Neurologic Subspecialties in headache medicine and has been named a “Top Doc” by Philadelphia Magazine and awarded the Lifetime Achievement Award by the American Headache Society, among more than a dozen other awards.
Silberstein received his medical degree from the Perelman School of Medicine at the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Silberstein served as a pharmacology research associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health in Maryland and completed a neurology residency at the Hospital of the University of Pennsylvania.
“Neurology is exciting, and the field is moving fast. I hope to share the excitement with my friends and colleagues,” Silberstein said.
Among his long list of accolades, Silberstein has held multiple editorial and advisory board responsibilities for major headache, migraine and pain publications, and has authored or co-authored more than 300 peer-reviewed articles and abstracts. A fellow of the American Headache Society, the American Academy of Neurology, and the American College of Physicians, he has also been a long-serving member and previous past president of the American Headache Society and has co-chaired the society’s annual scientific meeting.
A digital and print media platform for health care professionals treating neurological diseases, NeurologyLive™ delivers direct access to practice-changing news and expert insight directly from top medical conferences and researchers to improve the lives of patients with neurological diseases such as dementia and Alzheimer disease, epilepsy, headache and migraine, movement disorders, multiple sclerosis, neuromuscular diseases, sleep medicine and stroke. The NeurologyLive™ platform offers an in-depth look at the hundreds of new treatments in development with ever-expanding mechanisms of action, all during an unprecedented time of growing demand for neurology expertise. The NeurologyLive™ platform also connects visitors with the most up-to-date clinical trial results, Food and Drug Administration approvals, practice-changing research and expert insight. NeurologyLive™ is part of the Cranbury, New Jersey-based MJH Associates, Inc. family of businesses, which includes OncLive® and CURE® magazine. For more information, visit http://www.mjhassoc.com.